A scoping review and concept analysis to inform Canada’s safe(r) opioid supply research agenda
Uyen Do, Sarah Larney, Matthew Bonn, Ingrid Matei, Camille Zolopa, Amy Bergeron, Mohammad Karamouzian, Elaine Hyshka, Thomas D. Brothers, Nikki Bozinoff, Dan Werb, Didier Jutras‑Aswad, Stine Høj, Isabelle Boisvert, Igor Yakovenko, Julie Bruneau, International Journal of Drug Policy, 2025
Indigenous peoples and medications for opioid use disorders: A scoping review
Gala N, Dobischok S, Bernett P, Parker DG, O’Callahan A, Zentner D, Huson K, Tomaro J, Wendt DC., Psychol Addict Behav. 2025
Experiences, impacts, and perspectives of recreational cannabis use among Indigenous communities: A scoping review
Zentner D, Dobischok S, DeGrace S, Wen RA, Wendt DC., Psychol Addict Behav. 2025
Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis
Bastien G, McAnulty C, Sharafi H, Mahroug A, Elkrief L, Ziegler D, Dubreucq S, Juteau LC, Jutras-Aswad D., J Addict Med. 2025
A scoping review of harm reduction practices and possibilities among indigenous populations in Australia, Canada, and the United States
Zolopa C, Clifasefi SL, Dobischok S, Gala N, Fraser-Purdy H, Phillips MK, Blackmore S, Wendt DC, Drug Alcohol Depend. 2025
Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update
Tatar O, Bakouni H, Abdel-Baki A, Jutras-Aswad D., Cannabis Cannabinoid Res. 2025
